Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM.NS

269.25 (INR) • At close August 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20252024202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 553.61224.63348.085273.191218.72394.14890.028-116.267143.96740.75316.71725.31318.32774.56892.681105.00198.98551.91928.02926.254
Depreciation & Amortization 81.3116.6312.05415.26210.8611.29810.15810.62319.9430.93627.06928.25427.07625.35822.00920.8512.49816.87216.51915.093
Deferred Income Tax 00-77.62600000000000000000
Stock Based Compensation 68.04133.187.6500000000000000000
Change In Working Capital 33.8655.3998.743-171.294115.94342.54197.10487.881-61.307-19.56-40.938-26.53425.024-75.138-14.021-87.338107.80411.313-17.8013.38
Accounts Receivables -22.2591.54-55.56-29.5587.894-7.03244.034142.59322.77331.9863.321-30.1931.05800000-94.845129.309
Inventory 0.0153.190.657-0.176-3.99533.676187.412-38.147-77.816-67.755-24.728-5.20851.478126.63-1.251-4.227115.011107.014102.556-128.52
Accounts Payables 21.38-89.82-19.62-10.7563.406-1.51127.6781.103-7.44518.5780000000000
Other Working Capital 56.10.5783.266-130.818-31.36217.407-62.02126.02816.50948.195-16.21-21.326-26.454-201.768-12.77-83.111-7.207-95.701-25.5122.591
Other Non Cash Items -183.82-78.09-2.366-61.178-63.302-35.51611.6932.004-135.01538.25640.13248.1550.06846.042-36.108-29.961-41.132-24.223-3.065-28.866
Operating Cash Flow 553351.66466.54155.981282.224112.47308.983-15.759-32.41590.38542.9875.183120.49570.8364.5618.552178.15555.88123.68215.861
Investing Activities:
Investments In Property Plant And Equipment -3.48-2.48-3.176-4.675-4.691-20.68-22.549-38.279-25.792-27.488-5.753-12.752-37.171-53.091-70.088-20.997-84.791-47.245-89.17-68.886
Acquisitions Net -936.57012.965.810022.5490434.02700000000000
Purchases Of Investments -2,556.34-1,354.07-1,032.96-284.486-41.728-113.86300000000000000
Sales Maturities Of Investments 2,609.341,037.4412.19-5.810000000000000000
Other Investing Activites 435.5873.6734.27927.08223.77626.916-8.2594.568438.7166.5641.110.6073.2313.692000000
Investing Cash Flow -451.47-245.48-576.707-262.079-22.643-107.627-8.259-33.711412.924-20.924-4.643-12.145-33.94-49.399-70.088-20.997-84.791-47.245-89.17-68.886
Financing Activities:
Debt Repayment -9.0200-67.8808.794-45.1513.724-305.646-8.17833.5328.71-15.36762.9267.1170-854.99967.24855.22
Common Stock Issued 33.9156.35000000000000000000
Common Stock Repurchased 0000-36.947000000000000000
Dividends Paid -132.29-130.990-104.79-26.2-13.1-6.55-2.62-3.153-2.62-2.62-13.099-13.099-13.099000000
Other Financing Activities -9.58-14.47-3.2265.027-5.135-13.935-8.801-7.105-26.981-53.503-45.109-56.047-53.46-2.12513.09912.768-12.366-95.14500
Financing Cash Flow -116.98-89.11-4.567-123.038-68.282-9.447-60.502-6.001-335.247-64.301-14.199-40.436-81.9264.127.11712.768-97.366-8.37667.24855.22
Other Information:
Effect Of Forex Changes On Cash 000.003-35.033017.388000-0.001-0.001-0.002-0.002-0.001000000
Net Change In Cash -15.4517.07-114.733-329.136191.299-4.604240.222-55.47145.2625.15924.13722.64.62725.551.5890.323-4.0020.25900
Cash At End Of Period 112.15127.6110.531260.293589.429380.742385.346145.124200.595155.333150.174126.034103.43498.8073.7032.1141.7915.79335.55638.88